We are aware of current issues with the ONS login. Users who already have an account with ONS should clear their device history/cache before attempting to log in. Thank you.
cancel
Oncology Drug Reference Sheet: Decitabine and Cedazuridine
Kristine B. LeFebvre DNP, RN, NPD-BC, AOCN®
Voice
Description
In July 2020, the U.S. Food and Drug Administration approved decitabine and cedazuridine (Inqovi®) tablets for the treatment of adults with myelodysplastic syndromes (MDS).